NIH RADx Initiative
National institution of health (NIH)- Rapid Acceleration of Diagnostics (RADx) initiative
Subsidy: no limit (total budget $500M)
Deadline: a rolling basis and will be reviewed within a week of receipt. Progression to ‘ deep dive stage’ upon invitation.
Consortium: US scientists and inventors
Scope: To address the COVID-19 pandemic, this program is anticipated to support the fast track development of new tests with improved technical performance and convenience, such as point-of-care and home devices, as well as innovations that make current lab tests faster, more efficient, and more widely accessible. Focus is on improving analytical or operational performance, improving access and reducing cost of testing. NIBIB will consider innovations at all stages of readiness from early to late stage and from novel testing strategies to optimization of existing SARS-CoV-2 testing approaches. NIBIB will support the full range of product development including commercialization and product distribution. NIH will supply the needed budget, partnerships and other resources to fully deploy successful tests to the public on the shortest possible timeline. NIH will negotiate cost sharing with for-profit institutions as appropriate.
The subsidy landscape is responding quickly to the COVID-19 virus and the problems this crisis causes world-wide. A lot of new funding opportunities are being released to assist researchers and companies with their Research and Development activities against COVID-19. We have made an overview of all COVID-19 grants & funding opportunities. Check our COVID-19 Call Overview and stay up-to-date.
A more detailed and tailor-made overviews are available in 3 different products:
- Funding Scan. A summarized overview of funding opportunities for one specific R&D project with a short profile of the researcher or company. This includes a strategy with upcoming funding opportunities for the next year.
- Funding Advice. A detailed description of your company, research group, R&D projects and an overview of the timelines involved in future development. This includes a funding strategy for each project for the next 2 years.
- Funding Plan. A long-term funding strategy taking into consideration multiple R&D pillars. This detailed strategy focuses on multiple sources of funding and addresses financial weaknesses in continuing strategic planning.
Read more about it on our Strategic Funding Advice page.